Genfit SA - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Genfit SA - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Genfit SA - Product Pipeline Review - 2014', provides an overview of the Genfit SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Genfit SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Genfit SA including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Genfit SA's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Genfit SA's pipeline products

Reasons to buy

- Evaluate Genfit SA's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Genfit SA in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Genfit SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Genfit SA and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Genfit SA
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Genfit SA and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Genfit SA Snapshot 5
Genfit SA Overview 5
Key Information 5
Key Facts 5
Genfit SA - Research and Development Overview 6
Key Therapeutic Areas 6
Genfit SA - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Genfit SA - Pipeline Products Glance 11
Genfit SA - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Genfit SA - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Genfit SA - Drug Profiles 15
GFT-505 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
TGFTX-3 Program 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
SAN/GFT-2 Program 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
SERX-1 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
TGFTX-1 Program 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
TGFTX-4 Program 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
TGFTX-5 Program 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Genfit SA - Pipeline Analysis 24
Genfit SA - Pipeline Products by Target 24
Genfit SA - Pipeline Products by Route of Administration 25
Genfit SA - Pipeline Products by Molecule Type 26
Genfit SA - Pipeline Products by Mechanism of Action 27
Genfit SA - Recent Pipeline Updates 28
Genfit SA - Dormant Projects 33
Genfit SA - Discontinued Pipeline Products 34
Discontinued Pipeline Product Profiles 34
AVE-0847 34
AVE-8134 34
GFT-14 34
Genfit SA - Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37

List of Tables
Genfit SA, Key Information 5
Genfit SA, Key Facts 5
Genfit SA - Pipeline by Indication, 2014 8
Genfit SA - Pipeline by Stage of Development, 2014 9
Genfit SA - Monotherapy Products in Pipeline, 2014 10
Genfit SA - Phase II, 2014 11
Genfit SA - Phase I, 2014 12
Genfit SA - Preclinical, 2014 13
Genfit SA - Discovery, 2014 14
Genfit SA - Pipeline by Target, 2014 24
Genfit SA - Pipeline by Route of Administration, 2014 25
Genfit SA - Pipeline by Molecule Type, 2014 26
Genfit SA - Pipeline Products by Mechanism of Action, 2014 27
Genfit SA - Recent Pipeline Updates, 2014 28
Genfit SA - Dormant Developmental Projects,2014 33
Genfit SA - Discontinued Pipeline Products, 2014 34
Genfit SA, Subsidiaries 35